CDK1 and thyroid cancer: The correlations between ganetespib sensitivity and decreases in CDK1 levels, or decreases in phosphorylated or total levels of ERK1/2, AKT, 4E-BP1, S6 ribosomal protein and RET in eight thyroid cancer cell lines were not specifically evaluated in this study.